- Home
- ORMP vs BMN Comparison
ORMP vs BMN Comparison
Compare ORMP & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | BMN |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 158.7M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ORMP | BMN |
|---|---|---|
| Price | $3.85 | $25.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 191.0K | 7.4K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.22 | ★ N/A |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $23.96 |
| 52 Week High | $5.01 | $27.96 |
Technical Indicators
Market Signals| Indicator | ORMP | BMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 47.68 |
| Support Level | $3.83 | $25.49 |
| Resistance Level | $3.96 | $26.31 |
| Average True Range (ATR) | 0.18 | 0.46 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 61.39 | 38.36 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.